Boeke S, Habrich J, Kubler S, Boldt J, Schick F, Nikolaou K
Radiat Oncol. 2025; 20(1):15.
PMID: 39881423
PMC: 11780986.
DOI: 10.1186/s13014-025-02589-9.
Bonate R, Awan M, Himburg H, Wong S, Shukla M, Tarima S
Phys Imaging Radiat Oncol. 2025; 33:100693.
PMID: 39877149
PMC: 11772986.
DOI: 10.1016/j.phro.2024.100693.
Subashi E, LoCastro E, Burleson S, Apte A, Zelefsky M, Tyagi N
Phys Imaging Radiat Oncol. 2024; 32():100678.
PMID: 39717186
PMC: 11665667.
DOI: 10.1016/j.phro.2024.100678.
Aliotta E, Paudyal R, Dresner A, Shukla-Dave A, Lee N, Cervino L
Phys Imaging Radiat Oncol. 2024; 32:100653.
PMID: 39399877
PMC: 11466654.
DOI: 10.1016/j.phro.2024.100653.
Hanekamp B, Virdee P, Goh V, Jones M, Hansen R, Johannesen H
Phys Imaging Radiat Oncol. 2024; 31:100618.
PMID: 39188809
PMC: 11345337.
DOI: 10.1016/j.phro.2024.100618.
Prediction of overall survival in patients with locally advanced pancreatic cancer using longitudinal diffusion-weighted MRI.
Bisgaard A, Brink C, Schytte T, Bahij R, Weisz Ejlsmark M, Bernchou U
Front Oncol. 2024; 14:1401464.
PMID: 39091912
PMC: 11291378.
DOI: 10.3389/fonc.2024.1401464.
Dataset of weekly intra-treatment diffusion weighted imaging in head and neck cancer patients treated with MR-Linac.
El-Habashy D, Wahid K, He R, McDonald B, Mulder S, Ding Y
Sci Data. 2024; 11(1):487.
PMID: 38734679
PMC: 11088675.
DOI: 10.1038/s41597-024-03217-z.
Validation of echo planar imaging based diffusion-weighted magnetic resonance imaging on a 0.35 T MR-Linac.
Wallimann P, Piccirelli M, Nowakowska S, Armstrong T, Mayinger M, Boss A
Phys Imaging Radiat Oncol. 2024; 30:100579.
PMID: 38707628
PMC: 11068927.
DOI: 10.1016/j.phro.2024.100579.
Repeatability and reproducibility of prostate apparent diffusion coefficient values on a 1.5 T magnetic resonance linear accelerator.
Fernando N, Tadic T, Li W, Patel T, Padayachee J, Santiago A
Phys Imaging Radiat Oncol. 2024; 30:100570.
PMID: 38544680
PMC: 10966090.
DOI: 10.1016/j.phro.2024.100570.
Repeatability quantification of brain diffusion-weighted imaging for future clinical implementation at a low-field MR-linac.
Rabe M, Dietrich O, Forbrig R, Niyazi M, Belka C, Corradini S
Radiat Oncol. 2024; 19(1):31.
PMID: 38448888
PMC: 10916154.
DOI: 10.1186/s13014-024-02424-7.
The Use of MR-Guided Radiation Therapy for Head and Neck Cancer and Recommended Reporting Guidance.
McDonald B, Dal Bello R, Fuller C, Balermpas P
Semin Radiat Oncol. 2023; 34(1):69-83.
PMID: 38105096
PMC: 11372437.
DOI: 10.1016/j.semradonc.2023.10.003.
Accurate, repeatable, and geometrically precise diffusion-weighted imaging on a 0.35 T magnetic resonance imaging-guided linear accelerator.
Weygand J, Armstrong T, Bryant J, Andreozzi J, Oraiqat I, Nichols S
Phys Imaging Radiat Oncol. 2023; 28:100505.
PMID: 38045642
PMC: 10692914.
DOI: 10.1016/j.phro.2023.100505.
Development and implementation of optimized endogenous contrast sequences for delineation in adaptive radiotherapy on a 1.5T MR-linear-accelerator: a prospective R-IDEAL stage 0-2a quantitative/qualitative evaluation of site-specific....
Salzillo T, Dresner M, Way A, Wahid K, McDonald B, Mulder S
J Med Imaging (Bellingham). 2023; 10(6):065501.
PMID: 37937259
PMC: 10627232.
DOI: 10.1117/1.JMI.10.6.065501.
Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5 T MR-linear accelerator hybrid system: A prospective R-IDEAL stage 2a imaging biomarker characterization/pre-qualification study.
Clin Transl Radiat Oncol. 2023; 42:100666.
PMID: 37583808
PMC: 10424120.
DOI: 10.1016/j.ctro.2023.100666.
Optimising the MR-Linac as a standard treatment modality.
de Leon J, Twentyman T, Carr M, Jameson M, Batumalai V
J Med Radiat Sci. 2023; 70(4):491-497.
PMID: 37540059
PMC: 10715353.
DOI: 10.1002/jmrs.712.
Recommendations for improved reproducibility of ADC derivation on behalf of the Elekta MRI-linac consortium image analysis working group.
Bisgaard A, Keesman R, van Lier A, Coolens C, van Houdt P, Tree A
Radiother Oncol. 2023; 186:109803.
PMID: 37437609
PMC: 11197850.
DOI: 10.1016/j.radonc.2023.109803.
Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study.
Almansour H, Schick F, Nachbar M, Afat S, Fritz V, Thorwarth D
Radiol Oncol. 2023; 57(2):184-190.
PMID: 37341194
PMC: 10286890.
DOI: 10.2478/raon-2023-0020.
Prospective evaluation of in vivo and phantom repeatability and reproducibility of diffusion-weighted MRI sequences on 1.5 T MRI-linear accelerator (MR-Linac) and MR simulator devices for head and neck cancers.
McDonald B, Salzillo T, Mulder S, Ahmed S, Dresner A, Preston K
Radiother Oncol. 2023; 185:109717.
PMID: 37211282
PMC: 10527507.
DOI: 10.1016/j.radonc.2023.109717.
Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5T MR-Linear accelerator hybrid system: A prospective R-IDEAL Stage 2a imaging biomarker characterization/ pre-qualification study.
El-Habashy D, Wahid K, He R, McDonald B, Rigert J, Mulder S
medRxiv. 2023; .
PMID: 37205359
PMC: 10187456.
DOI: 10.1101/2023.05.04.23289527.
Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions.
Bryant J, Weygand J, Keit E, Cruz-Chamorro R, Sandoval M, Oraiqat I
Cancers (Basel). 2023; 15(7).
PMID: 37046741
PMC: 10093051.
DOI: 10.3390/cancers15072081.